Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Revenue (2020 - 2025)

Historic Revenue for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $260000.0.

  • Insight Molecular Diagnostics' Revenue rose 12608.7% to $260000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 52087.45%. This contributed to the annual value of $1.9 million for FY2024, which is 2514.97% up from last year.
  • Insight Molecular Diagnostics' Revenue amounted to $260000.0 in Q3 2025, which was up 12608.7% from $518000.0 recorded in Q2 2025.
  • Insight Molecular Diagnostics' 5-year Revenue high stood at $3.6 million for Q4 2021, and its period low was $67000.0 during Q3 2022.
  • Its 5-year average for Revenue is $843631.6, with a median of $429000.0 in 2023.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Revenue surged by 692500.0% in 2021, and later tumbled by 9319.11% in 2022.
  • Insight Molecular Diagnostics' Revenue (Quarter) stood at $3.6 million in 2021, then crashed by 92.37% to $274000.0 in 2022, then grew by 14.6% to $314000.0 in 2023, then skyrocketed by 373.25% to $1.5 million in 2024, then plummeted by 82.5% to $260000.0 in 2025.
  • Its Revenue stands at $260000.0 for Q3 2025, versus $518000.0 for Q2 2025 and $2.1 million for Q1 2025.